David C. Bupp

2010

In 2010, David C. Bupp earned a total compensation of $1.1M as President and Chief Executive Officer at Navidea Biopharmaceuticals, a 11% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$107,500
Salary$355,000
Stock Awards$584,700
Other$8,887
Total$1,056,087

Bupp received $584.7K in stock awards, accounting for 55% of the total pay in 2010.

Bupp also received $107.5K in non-equity incentive plan, $355K in salary and $8.9K in other compensation.

Rankings

In 2010, David C. Bupp's compensation ranked 5,088th out of 10,439 executives tracked by ExecPay. In other words, Bupp earned more than 51.3% of executives.

ClassificationRankingPercentile
All
5,088
out of 10,439
51st
Division
Manufacturing
1,826
out of 3,838
52nd
Major group
Chemicals And Allied Products
376
out of 921
59th
Industry group
Drugs
223
out of 680
67th
Industry
In Vitro and In Vivo Diagnostic Substances
11
out of 51
78th
Source: SEC filing on July 10, 2012.

Bupp's colleagues

We found four more compensation records of executives who worked with David C. Bupp at Navidea Biopharmaceuticals in 2010.

2010

Mark Pykett

Navidea Biopharmaceuticals

Chief Executive Officer

2010

Frederick Cope

Navidea Biopharmaceuticals

Chief Scientific Officer

2010

Brent Larson

Navidea Biopharmaceuticals

Chief Financial Officer

2010

Rodger Brown

Navidea Biopharmaceuticals

Vice President, Global Regulatory Operations and Quality Assurance

You may also like